MOLLY BYLSMA: Open Payments
NPI 1164813838 · SMITHS GROVE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 6 payments from 4 companies in 2025. Trend: 2023 $83 · 2024 $172 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Wegovy, Rybelsus, XIFAXAN, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
